Phase 1 Two-way Drug Interaction Study of Deupirfenidone (LYT-100) and Nintedanib in Healthy Volunteers

Celea Therapeutics 
6 Tide Street, Suite 400
Boston, MA 02210

info@celeatx.com

DEUPIRFENIDONE
PATIENTS & PHYSICIANS
ABOUT US
CAREERS
NEWS & PUBLICATIONS
CONTACT

© 2026 Celea Therapeutics, Inc. All rights reserved. Expanded Access Policy

The FDA and corresponding regulatory authorities will ultimately review our clinical results and determine whether deupirfenidone is safe and effective. No regulatory agency has made any such determination that deupirfenidone is safe or effective for use by the general public for any indication.